BOC International Report issue

Contributed to NME For profit Phase 3
Founded: London United Kingdom (1886)
Status: No NME R&D (1886)

Organization Overview

First Clinical Trial
None
First Marketed Drug
2013
nitrogen
First NDA Approval
2013
carbon dioxide (dry ice)
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Marketed Drugs (5)

Key: BOC International (4) Acquired (1)

carbon dioxide (dry ice) (2013 NDA)

helium (2014)

nitric oxide (inomax) (2018)

nitrogen (2013)

oxygen (2013)

Drugs in Phase 3 Trials (2)

Key: BOC International (0) Acquired (2)

propofol (diprivan) (1 trial)

xenon xe-133 (1 trial)

Drugs in Other Trials (2)

Key: BOC International (0) Acquired (2)

nitrous oxide (1 trial)

oxygen (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 3
  • # of Trial APIs: 4